Webinars & e-learning courses All webinars

Non-Chemotherapy Options for Cancer

Non-Chemotherapy Options for Cancer
Non-Chemotherapy Options for Cancer

There are many ways to attack cancer, chemotherapy is NOT the only medical treatment. This lecture will touch on some more recent therapies such as immunotherapy, small molecule inhibitors and monoclonal antibodies.

Language: English

In case you have missed this webinar, you have the opportunity to watch a recorded version here.

This webinar qualifies for one (1) hour of continuing education.

Speaker:

Laura_photo_resized.jpg

Laura Brockley

DVM, BVSc, MANZCVS, FANZCVS

Dr Laura Brockley obtained her Bachelor of Veterinary Science with honours from the University of Melbourne in 2001.  She initially worked in small animal and mixed practices in Victoria and the United Kingdom, including teaching students at the Royal College in London.  Laura completed an internship and residency in Veterinary Oncology at the Melbourne Veterinary Specialist Centre in 2011.  In 2013 she became a registered specialist in Veterinary Oncology (Fellow of the Australian and New Zealand College of Veterinary Scientists).  Laura has a strong clinical interest in immunotherapy, lymphoma diagnostics and treatment, and using evidence-based medicine to provide compassionate care to cancer patients.  She advocates spending the time to ensure pet owners are making an informed decision on treatment options ranging from palliative to potentially curative in intent. Laura is actively involved in continuing education, including lecturing Veterinary nursing students and examining our next generation of oncology specialists.

Booking information

Duration: 0:56 h
Speaker: Laura Brockley
from 1
54.90 US$
(inkl. tax)

You might also be interested in

webinar-pic 3x2.jpg
Stephanie Colthurst
0:51 h

Common Malignancies of the Skin - Mast Cell Tumors and Soft Tissue Sarcomas in Dogs and Cats

Tumors of the skin and subcutaneous tissues are the most common malignancies in dogs and cats accounting for over 30-40% of tumors in dogs and 29% in cats...
lumbectomies 300x200.png
Barney Dean
1:07 h

Don't Get Stumped by Lumps - Approaching Tricky Lumpectomies 

This webinar will discuss the rationale behind sound investigation and management of tricky mass removals, and how to adapt a plan to suit owner circumstances. 
 
staging-the-oncology-patient.png
Laura Brockley
0:57 h

Staging the Oncology Patient

Staging is one of the most important components of oncology case management. It involves determining the extent of local disease along with the presence or absence of regional or distant metastasis. The results of staging are used to give more accurate and informed treatment options along with prognostic information for each oncology patient. Some of the biggest challenges in staging is to consider how much staging is required for each case, which are the most appropriate tests, and if the results of these tests will impact treatment options and prognosis. I will discuss this information in a case-based and evidence-based approach, focusing on some of the more common cancers including canine mast cell tumours, lymphoma, oral tumours and apocrine gland anal sac adenocarcinomas.